SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-10-004940
Filing Date
2010-08-09
Accepted
2010-08-09 16:31:00
Documents
13
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS 10-Q a6385699.htm 10-Q 811224
2 EXHIBIT 10.1 a6385699ex10-1.htm EX-10.1 773981
3 EXHIBIT 10.2 a6385699ex10-2.htm EX-10.2 10961
4 EXHIBIT 10.4 a6385699ex10-4.htm EX-10.4 102588
5 EXHIBIT 10.5 a6385699ex10-5.htm EX-10.5 105970
6 EXHIBIT 10.6 a6385699ex10-6.htm EX-10.6 87282
7 EXHIBIT 10.7 a6385699ex10-7.htm EX-10.7 88050
8 EXHIBIT 10.8 a6385699ex10-8.htm EX-10.8 101449
9 EXHIBIT 10.9 a6385699ex10-9.htm EX-10.9 91387
10 EXHIBIT 10.10 a6385699ex10-10.htm EX-10.10 87235
11 EXHIBIT 31.1 a6385699ex31-1.htm EX-31.1 14790
12 EXHIBIT 31.2 a6385699ex31-2.htm EX-31.2 16270
13 EXHIBIT 32.1 a6385699ex32-1.htm EX-32.1 9270
  Complete submission text file 0001157523-10-004940.txt   2302170
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21696 | Film No.: 101001994
SIC: 2836 Biological Products, (No Diagnostic Substances)